Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), ranging from ...

Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first ...

recovery of paired heavy and light chain sequences and analysis, high-throughput re-expression, and subsequent analysis including ELISA, Flow Cytometry, and BLI for the validation of antibody ...

Nona Biosciences' proprietary Harbour Mice® platform employs transgenic mice to generate fully human monoclonal antibodies in ...

Nona Biosciences' proprietary Harbour Mice® platform employs transgenic mice to generate fully human monoclonal antibodies in both the conventional two heavy and two light chain (H2L2 ...

Antibody molecules ... are found to have a fundamentally similar structure consisting of two heavy and two light peptide chains. Recent studies of the amino-acid sequences of these chains are ...

Harbour BioMed's proprietary antibody technology platform, Harbour Mice ®, generates fully human monoclonal antibodies in both the conventional two heavy and two light chain (H2L2) format and the ...

Genmab presents a long-term investment opportunity, but uncertainties around Darzalex's pending patent expiration warrant a ...